Project overview
Dupilumab is a drug used in treatment of skin condition: eczema. Up to 22 % of patients treated with this drug in initial studies have been reported to have ocular complications, in form of either dry eye or conjunctivitis. We want to explore dupilumab related ocular findings in cohort of patients referred to ophthalmology clinics at Southampton University Hospital, in order to review patterns of presentation, need for treatment and gain knowledge on details of the ocular co-morbidity of dupilumab treatment. This study plans to retrospectively collect data on patients referred to the eye department with ocular problems due to dupilumab therapy.
Staff
Lead researchers
Research outputs
Magdalena Z Popiela, Ramez Barbara, Andrew M J Turnbull, Emma Corden, Beatriz Suarez Martinez-Falero, Daniel O'Driscoll, Michael R Ardern-Jones & Parwez N Hossain,
2021, Eye, 35(12), 3277-3284
Type: article